Why does this matter in vivo? Using a synergist ablation overload, we show that tendon maladaptation develops over time. Genetic inhibition of HIF1α in tendon fibroblasts preserves tendon structure and mechanics. This supports HIF1α-regulated pathways as potential therapeutic entry point. (7/8)
